Further investigations showed that GALNT4 attenuates the stemness and anchorage-independent survival of hepatocellular carcinoma cells in vitro and inhibits cancer cell growth in vivo partly via inactivating epidermal growth factor receptor (EGFR) [29]. Here, EGFR is linked to cancer.